Literature DB >> 11517646

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.

T J Bungard, W A Ghali, F A McAlister, A M Buchan, A J Cave, P G Hamilton, L B Mitchell, A Shuaib, K K Teo, R T Tsuyuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11517646      PMCID： PMC81330     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Why do patients with atrial fibrillation not receive warfarin?

Authors:  T J Bungard; W A Ghali; K K Teo; F A McAlister; R T Tsuyuki
Journal:  Arch Intern Med       Date:  2000-01-10

2.  The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.

Authors: 
Journal:  Arch Intern Med       Date:  1997-06-09

3.  Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project.

Authors:  H J Chang; J R Bell; D B Deroo; J W Kirk; J H Wasson
Journal:  Arch Intern Med       Date:  1990-01

4.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

5.  Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

Authors:  D C McCrory; D B Matchar; G Samsa; L L Sanders; E L Pritchett
Journal:  Arch Intern Med       Date:  1995-02-13
  5 in total
  17 in total

Review 1.  Explicit risk in acute coronary syndrome management.

Authors:  Merril L Knudtson; Colleen M Norris; P Diane Galbraith; Jaro Hubacek; William A Ghali
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

2.  Capsule commentary on Efird et al., identifying the risks of anticoagulation in patients with substance abuse.

Authors:  Katherine Kirley
Journal:  J Gen Intern Med       Date:  2013-10       Impact factor: 5.128

3.  What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.

Authors:  Anders Ingelgård; Jennifer Hollowell; Prabashni Reddy; Karen Gold; Kimbach Tran; David Fitzmaurice
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

4.  New treatment options for stroke prevention in atrial fibrillation.

Authors:  Benjamin Rhee; Richard L Page
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

5.  International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation.

Authors:  Jorge Suarez; Jonathan P Piccini; Li Liang; John J Atherton; Christopher S Hayward; Henry Krum; Gregg C Fonarow; Renato D Lopes; Adrian F Hernandez
Journal:  Am Heart J       Date:  2012-03-27       Impact factor: 4.749

Review 6.  Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?

Authors:  Rik Willems; Derek V Exner
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 7.  The decision to anticoagulate: assessing whether benefits outweigh the risks for patients with atrial fibrillation.

Authors:  Geno Merli; Howard H Weitz
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

8.  Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.

Authors:  Anne Holbrook; Renée Labiris; Charles H Goldsmith; Kaede Ota; Sandra Harb; Rolf J Sebaldt
Journal:  CMAJ       Date:  2007-05-22       Impact factor: 8.262

9.  Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.

Authors:  Mark H Eckman; Gregory Y H Lip; Ruth E Wise; Barbara Speer; Megan Sullivan; Nita Walker; Brett Kissela; Matthew L Flaherty; Dawn Kleindorfer; Peter Baker; Robert Ireton; Dave Hoskins; Brett M Harnett; Carlos Aguilar; Anthony Leonard; Lora Arduser; Dylan Steen; Alexandru Costea; John Kues
Journal:  J Am Geriatr Soc       Date:  2016-05       Impact factor: 5.562

10.  A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643].

Authors:  Finlay A McAlister; Malcolm Man-Son-Hing; Sharon E Straus; William A Ghali; Paul Gibson; David Anderson; Jafna Cox; Miriam Fradette
Journal:  BMC Cardiovasc Disord       Date:  2004-05-05       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.